Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1988 5
1989 3
1990 1
1991 2
1997 1
2005 1
2007 1
2009 1
2010 5
2011 2
2012 2
2013 2
2014 1
2015 3
2017 2
2020 6
2021 2
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Effects of Beta-Blocker Withdrawal in Acute Decompensated Heart Failure: A Systematic Review and Meta-Analysis.
Prins KW, Neill JM, Tyler JO, Eckman PM, Duval S. Prins KW, et al. JACC Heart Fail. 2015 Aug;3(8):647-53. doi: 10.1016/j.jchf.2015.03.008. JACC Heart Fail. 2015. PMID: 26251094 Free PMC article. Review.
RESULTS: Five observational studies and 1 randomized clinical trial (n = 2,704 patients who continued beta-blocker therapy and n = 439 patients who discontinued beta-blocker therapy) that reported the short-term effects of beta-blocker withdrawal in ADHF were …
RESULTS: Five observational studies and 1 randomized clinical trial (n = 2,704 patients who continued beta-blocker therapy and n = 43 …
Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF).
McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau J, Shi VC, Solomon SD, Swedberg K, Zile MR; PARADIGM-HF Committees and Investigators. McMurray JJ, et al. Eur J Heart Fail. 2013 Sep;15(9):1062-73. doi: 10.1093/eurjhf/hft052. Epub 2013 Apr 5. Eur J Heart Fail. 2013. PMID: 23563576 Free PMC article. Clinical Trial.
Nontuberculous mycobacterial lung disease.
Griffith DE. Griffith DE. Curr Opin Infect Dis. 2010 Apr;23(2):185-90. doi: 10.1097/QCO.0b013e328336ead6. Curr Opin Infect Dis. 2010. PMID: 20087178 Review.
As with tuberculosis, the tumor-necrosis factor alpha (TNF-alpha) blockers also predispose to NTM infection that can be severe. The most frustrating aspect of NTM therapy remains the generally poor correlation between in-vitro antibiotic susceptibility and in-vivo response …
As with tuberculosis, the tumor-necrosis factor alpha (TNF-alpha) blockers also predispose to NTM infection that can be severe. The m …
The Use of β-Adrenergic Receptor Antagonists in Psychiatry: A Review.
Boyce TG, Ballone NT, Certa KM, Becker MA. Boyce TG, et al. J Acad Consult Liaison Psychiatry. 2021 Jul-Aug;62(4):404-412. doi: 10.1016/j.jaclp.2020.12.009. Epub 2021 Jan 11. J Acad Consult Liaison Psychiatry. 2021. PMID: 34210401 Review.
BACKGROUND: beta-Blockers (BBs) are a widely used class of medications with a number of medical indications. ...
BACKGROUND: beta-Blockers (BBs) are a widely used class of medications with a number of medical indications. ...
Amlodipine: an effective once-daily antihypertensive agent.
Tyler HM. Tyler HM. J Hum Hypertens. 1991 Aug;5 Suppl 1:61-6. J Hum Hypertens. 1991. PMID: 1834848 Review.
When used in combination with angiotensin converting enzyme inhibitors, beta-blockers or thiazide diuretics, amlodipine can produce important additional antihypertensive effects. ...
When used in combination with angiotensin converting enzyme inhibitors, beta-blockers or thiazide diuretics, amlodipine can produce i …
δ ENaC: a novel divergent amiloride-inhibitable sodium channel.
Ji HL, Zhao RZ, Chen ZX, Shetty S, Idell S, Matalon S. Ji HL, et al. Am J Physiol Lung Cell Mol Physiol. 2012 Dec 15;303(12):L1013-26. doi: 10.1152/ajplung.00206.2012. Epub 2012 Sep 14. Am J Physiol Lung Cell Mol Physiol. 2012. PMID: 22983350 Free PMC article. Review.
Management of Patients with Acute Coronary Syndrome and Cancer.
Moran TB, Plana JC. Moran TB, et al. Curr Cardiol Rep. 2020 Oct 10;22(12):159. doi: 10.1007/s11886-020-01409-8. Curr Cardiol Rep. 2020. PMID: 33037951 Review.
RECENT FINDINGS: Despite an elevated bleeding risk, many cancer patients may benefit from ACC/AHA guideline-directed management for ACS including aspirin, P2Y(12) inhibitor, statin, and beta-blocker therapies. Cancer patients with ACS are a uniquely vulnerable population w …
RECENT FINDINGS: Despite an elevated bleeding risk, many cancer patients may benefit from ACC/AHA guideline-directed management for ACS incl …
The safety of sacubitril-valsartan for the treatment of chronic heart failure.
Tyler JM, Teerlink JR. Tyler JM, et al. Expert Opin Drug Saf. 2017 Feb;16(2):257-263. doi: 10.1080/14740338.2017.1279144. Expert Opin Drug Saf. 2017. PMID: 28060547 Review.
Sacubitril-valsartan is a combination drug that contains the neprilysin inhibitor sacubitril and angiotensin II receptor blocker valsartan. In 2015, the US Food and Drug Administration approved sacubitril-valsartan for treatment of heart failure patients with reduced eject …
Sacubitril-valsartan is a combination drug that contains the neprilysin inhibitor sacubitril and angiotensin II receptor blocker vals …
42 results